Feb 27, 2025 · Selenium, with its antioxidative properties, has shown potential for improving Graves ophthalmopathy progression and quality of life (QOL); however, its effectiveness in selenium …

Objective: This study aimed to determine if selenium supplementation for a period of six months can decrease signs and prevent worsening of mild Graves’ ophthalmopathy among Filipino patients.

To compare serum selenium levels in Graves patients and non-Graves control participants and to evaluate associations between serum selenium levels and clinical features of Graves orbitopathy (GO).

The therapeutic efect of selenium has been demonstrated in mild Graves’ ophthalmopathy (GO) in a European region where selenium status is suboptimal. However, there is a lack of evidence to …

India Introduction The management of Graves’ ophthalmopathy (GO) is chal-lenging for both patients and endocrinologists. S. ch patients are ideally managed in a multidisciplinary setting with input from …

Patients were given 200 mcg of selenium daily in addition to standard care or standard of care alone, over a six-month period. The study commenced following approval from the University of Santo …

Selenium, with its antioxidative properties, has shown potential for improving Graves ophthalmopathy progression and quality of life (QOL); however, its effectiveness in selenium-sufficient regions is not …

Purpose: Graves' orbitopathy (GO) is the main extrathyroidal manifestation of Graves' disease. However, limited studies have investigated the actual efficacy of selenium in GO therapy. This …

The effect of selenium on the prognosis (improvement, unchanged and deteriora-tion) of Graves orbitopathy was evaluated by comparing ’ the GO-QOL total score between the selenium therapy …

Jan 26, 2021 · Based on the role of oxidative stress in the pathogenesis of Graves’ hyperthyroidism (GH) and Graves’ Orbitopathy (GO), a therapy with the antioxidant agent selenium has been …